BST Global Announces AI + Data Consortium to Transform the AEC Industry
BST Global, the leading provider of AI-powered project intelligence™ solutions for the AEC industry, is proud to announce the formation of its AI + Data Consortium, a group of global technology leaders with a mission to be the voice of AI-powered and data-driven innovation for the AEC industry. These visionaries will help transform the AEC industry’s future.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241015068391/en/
BST Global, the leading provider of AI-powered project intelligence™ solutions for the AEC industry, is proud to announce the formation of its AI + Data Consortium, a group of global technology leaders with a mission to be the voice of AI-powered and data-driven innovation for the AEC industry. These visionaries will help transform the AEC industry’s future. The AI + Data Consortium’s inaugural members are Tim Wark, Global AI Lead, AECOM; Tembi Hommes, Global Chief Data Officer, Arup; Darren Martin, Chief Digital Officer, AtkinsRéalis; Javier A. Baldor, Chief Executive Officer, BST Global; Eileen M. Canady, Chief Marketing Officer, BST Global; Joseph Joseph, Partner & Chief Digital Officer, Gensler; Ricardo Lorenzo, Chief Technology Officer, Parsons Corporation; Jason B. Miller, Head of Innovation, Ramboll; Shankar Kalyana, Senior Vice President & Chief Technology Officer, Stantec; and Chadi Habib, Chief Technology Officer & Business Solutions Manager, WSP. (Graphic: BST Global)
The AI + Data Consortium’s inaugural members are:
- Tim Wark, Global AI Lead, AECOM
- Tembi Hommes, Global Chief Data Officer, Arup
- Darren Martin, Chief Digital Officer, AtkinsRéalis
- Javier A. Baldor, Chief Executive Officer, BST Global
- Eileen M. Canady, Chief Marketing Officer, BST Global
- Joseph Joseph, Partner & Chief Digital Officer, Gensler
- Ricardo Lorenzo, Chief Technology Officer, Parsons Corporation
- Jason B. Miller, Head of Innovation, Ramboll
- Shankar Kalyana, Senior Vice President & Chief Technology Officer, Stantec
- Chadi Habib, Chief Technology Officer & Business Solutions Manager, WSP
Together, they will lead efforts to:
- Define industry best practices, standards and recommendations
- Collaborate on strategic projects that elevate the AEC industry
- Produce original industry research via global surveys focusing on AI and data
- Share industry-specific insights and information
- Make connections with peers to increase our knowledge network
- Promote industry and client advocacy
- Pool industry data for benchmarking, analysis and optimization
BST Global Chief Executive Officer Javier A. Baldor spearheaded the creation of the consortium and expects the group to have a profound and lasting impact on the AEC industry. According to Baldor, “There is a once-in-a-generation opportunity before us to reimagine and transform the future of our industry with AI, big data and emerging technologies. We are honored to bring together the AEC industry’s brightest minds and visionaries to meet this challenge and lead the way forward with our AI + Data Consortium.”
AECOM Global AI Lead Tim Wark echoed these sentiments, commenting, “I’m very excited to be joining a group of industry leaders of this caliber as we look ahead to the tremendous changes and opportunities that the current AI wave is bringing about across the AEC sector.”
Each of the consortium members will be speaking at BST Global’s AI Summit 2025 in Palm Beach scheduled for May 6–8, 2025. This year marks BST Global’s second annual AI Summit, a premier event focused on all things AI for the AEC industry. The conference brings leaders from the world’s top design, engineering and environmental consultancies together to share how they are preparing for an AI-powered and data-driven future. Last year’s event sold out quickly, so new and returning attendees are encouraged to register early to secure their spots. Event and registration details are available here.
BST GLOBAL
BST Global designs, develops and deploys the AEC industry’s first suite of AI-powered project intelligence™ solutions. Beyond our flagship ERP offering, we provide work management, predictive insights and resource management solutions to complement a firm’s existing ERP. More than 120,000 architects, engineers and consultants in 65 countries across six continents rely on BST Global’s solutions each day to successfully manage their projects, resources, finances and client relationships. With unrivaled industry knowledge, BST Global serves as a trusted partner to its loyal clients and remains at the forefront of innovation. For more information, visit www.BSTGlobal.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241015068391/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK™,a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press release
- ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies - - In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and further decreased sweat chloride compared to TRIKAFTA® - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and t
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press release
- Approximately 300 more people with cystic fibrosis in the U.S. are now eligible for a medicine that treats the underlying cause of their disease for the first time - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Andersen Global udvider sin ekspertise med tilføjelsen af Valora20.12.2024 17:07:00 CET | Pressemeddelelse
Andersen Global fortsætter sin udvidelse af servicetilbud gennem en samarbejdsaftale med Valora, der er en uafhængig virksomhed med speciale i levering af skræddersyede løsninger til både private og institutionelle kunder globalt. Valora har kontorer i Miami og Raleigh og desuden global tilstedeværelse i Den Dominikanske Republik, Storbritannien og Caymanøerne. Valora blev grundlagt i 2011 af partneren Luis de Leon og tilbyder et stort udvalg af tjenester, blandt andet værdiansættelse, performance, regnskab og administration, global enhedsstyring, fondsvirksomhed og andre skræddersyede løsninger. "Et samarbejde med Andersen passer godt til både vores kunder og vores team," siger Luis. "Synergierne mellem for vores servicetilbud vil sætte os i stand til at levere omfattende og integrerede løsninger med stadigt stigende global rækkevidde." Global Chairman og CEO for Andersen Mark L. Vorsatz udtaler: "Valoras team og virksomhedskultur er, sammen med deres fokus på det praktiske, et godt m
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom